Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan.

Yasutaka Hirasawa, Jiro Terada,Yu Shionoya, Atsushi Fujikawa,Yuri Isaka, Yuichiro Takeshita,Toru Kinouchi, Ken Koshikawa,Hiroshi Tajima, Taku Kinoshita,Yuji Tada, Koichiro Tatsumi,Kenji Tsushima

Respiratory investigation（2023）

引用 0|浏览2

暂无评分

摘要

In patients with COVID-19 pneumonia who required oxygen therapy, combination therapy with PBW-based dexamethasone, remdesivir, and baricitinib might not shorten the hospital stay's length or oxygen therapy's duration.

查看译文

关键词

COVID-19,Pneumonia,Dexamethasone,Predicted body weight

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要